For POCT, point-of-care testing, a lab has to purchase new equipment, perform new measurements and handle new parameters – right? Right! However, more importantly, POCT requires the adaptation and integration of the existing lab organisation, with all its consequences, from additional quality control down to new areas of responsibility. Dr Herbert Stekel is currently integrating three…
Antibiotic resistant bacteria lead to infections that are difficult to treat, particularly in hospitals. Multidrug-resistant Escherichia coli bacteria which have developed special enzymes that render antibiotics ineffective frequently cause such infections. DZIF scientists from Gießen University examined these bacteria more precisely and discovered a strain of Escherichia coli that has been…
Just as for other medical fields, DICOM is expected to play a significant role in pathology as a universal and fundamental standard in digital medical imaging. The value chain of solution components in a digital pathology lab is both long and complex, which makes the adoption of standards as DICOM all the more important. "One of the visions driving DICOM in general is to give users the…
In the modern world, ergonomics is everywhere – and when microscopy is a big part of your daily routine, ergonomics should be at the forefront. Olympus’ BX53 microscope is designed with laboratory professionals in mind, allowing the microscope to be customized so that every user can work in their ideal posture.
Researchers at the James Cook University Hospital, in Middlesbrough, UK, have developed a highly sensitive blood test that could be used before surgical operations to predict which patients are at risk of complications will survive in the long-term.
Modifying a DNA sequence to alter a cell to cure a disorder, prevent a genetic disease being passed on to next generations, or to use genetic modification as a way to diagnose a virus: yes, these tasks are possible. The recently discovered CRISPR technique can do it all.
Multidrug-resistant organisms (MDRO) are keeping infection specialists worldwide on their toes. One of these specialists travelled all the way from Leipzig to India to gain insights in one of the sources of the problem.
Neagen and Visiopharm announce an integration which improves the data quality of cancer patient samples in a single PACS-driven digital pathology workflow also offering time and cost savings. This in term enhances quality for pathologists working in cancer research and diagnostics and benefits the patients.
Hamamatsu Photonics introduces the NanoZoomer S360, a new high throughput Whole Slide Imaging scanner, engineered using Hamamatsu Photonics’ extensive experience of imaging technology and designed to meet the challenging requirements of digitizing routine clinical pathology.
Early adoption of image analytical tools and artificial intelligence are crucial if health systems across Europe are to see the full potential of digital pathology, according to a leading expert. While a growing number of European institutions are beginning to embrace digital pathology, Professor Johan Lundin remains concerned about the slow pace of progress. He acknowledges that more…
Certain members of Generation Y, who grew up alongside enormous information technology (IT) advances, now occupy decision-making roles. Meanwhile, generation Z is emerging into the continuing IT revolution; the digital world surrounds us.
In the nineties Deep Blue, the famous chess computer, defeated Kasparow. Only a year ago Google’s Deepmind managed to master the ancient Chinese Go, known for its utmost complexity.
Digital pathology has been the next big thing for about a decade. Yet, today only a few pathology laboratories are fully equipped to digitise their workflow, mainly for legal or financial reasons.
A national pathology image exchange platform for The Netherlands is expected to be in place and operational within the next 12 months.
Among the earliest centres to embrace the concept of digital pathology, the Leeds Digital Pathology Project began in 2003 thanks to a Department of Health grant. Today the centre is Europe’s largest.
Over recent years, virology, once medicine‘s step-child, moved into the limelight, pushed by impressive progress and pulled by globalisation-induced need for expertise in virus diagnostics and viral epidemics.
Antimicrobial resistance mortality is set to surpass cancer and traffic-related deaths by 2050, according to the UK National Health Service (NHS).
German researches have linked the increased production of a certain enzyme in the liver to fatty liver and insulin resistance.
Of the nearly 4 million women in the United States who have had either breast cancer or ovarian cancer, at least 1.5 million have a high risk of carrying certain types of genetic mutations that could increase their risk for additional cancers in the future.
The stimulant methamphetamine, also popularly known as ‘speed,’ ‘ice’ and ‘meth,’ is linked to a heightened risk of stroke among young people, reveals a review of the available evidence, published online in the Journal of Neurology Neurosurgery & Psychiatry.
Olympus BX46 and BX53 clinical microscopes feature the latest innovations in clinical microscopy, delivering comfortable, ergonomic setups, as well as accurate color rendering from a bright, durable light source.
The reasons why doctors request urinary analysis are varied – perhaps to detect a possible or suspected infection, or to screen for kidney diseases. In all cases a reliable and rapid result is the major aim. Urinary microscopy and culture have been the mainstays of urinary analysis for many, many years both of which require time and specialist handling.
In the 21 years since its launch in Germany, Kugel medical has become a leading manufacturer of histopathology equipment on a global level, with a presence in laboratories, forensic centres, universities, anatomical institutes, pharmacy firms and veterinary pathologies.
UK-based researchers believe personalised treatment for breast cancer is within sight after uncovering what they say is the most detailed picture to date of which genetic variations contribute to development of the disease.
New findings from a scientific collaboration between the German Cancer Research Centre (DKFZ), the National Centre for Tumour Diseases (NCT) Heidelberg and the Thoraxklinik Heidelberg suggest liquid biopsy as a promising tool to monitor lung cancer patient tumours early. Scientists associated liquid biopsy readouts with clinical data and could track tumour responses to cancer drugs in real-time.